Tenderwize
Retour à la recherche

Open Framework Agreement on Drug Discounts (2026-03)

Deutsche Rentenversicherung Knappschaft-Bahn-See·Bochum, Germany·Deadline Feb 05, 2028 · 527 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarder
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026­-03

0/100

Score d'opportunité

High riskLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

0 / 100

Complexité

10 / 100

Facteurs de risque

The notice explicitly cancels the procedure for all lots as of 30 June 2026. Participation is not possible.

No estimated contract value or award criteria (price/quality) are provided, making it impossible to assess commercial a...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Weak opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Mar 2028
  • Supply of pharmaceutical product Etanercept in four dosage forms (ILO, PEN, IFE, PLI) under a framework agreement for discount contracts (Rabattverträge).
  • The tender is cancelled and no longer accepting participation.
Afficher le résumé complet

This notice announces the cancellation of the open framework agreement for pharmaceutical discounts (Etanercept) under §130a Abs.8 SGB V, originally published on 11.12.2025 (notice 822904-2025). All four lots (ILO, PEN, IFE, PLI) are cancelled effective 30 June 2026. The tender is no longer open for participation.

Risques

The notice explicitly cancels the procedure for all lots as of 30 June 2026. Participation is not possible.

No estimated contract value or award criteria (price/quality) are provided, making it impossible to assess commercial a...

No procurement documents available

Exigences clés

Technical

  • Tender is cancelled as of 30 June 2026.
  • Original participation required pharmaceutical entrepreneur status per §4 Abs. 18 AMG.
  • Non-negotiable terms including fixed discount rate.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Bochum, DEU

Site web

www.kbs.de

Identifiant

992-80003-44

Activité

Health

Lots (4)

LOT-0001

Etanercept, injection (ILO)

Cancelled lot for Etanercept in ILO dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DEA51, Germany

Durée

Mar 2026 - Mar 2028

Catégorie

Pharmaceutical products

LOT-0002

Etanercept, pen (PEN)

Cancelled lot for Etanercept in PEN dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DEA51, Germany

Durée

Mar 2026 - Mar 2028

Catégorie

Pharmaceutical products

LOT-0003

Etanercept, injection (IFE)

Cancelled lot for Etanercept in IFE dosage form. Framework agreement with unlimited number of pharmaceutical entrepreneurs. Original period 01.04.2026–31.03.2028.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DEA51, Germany

Durée

Mar 2026 - Mar 2028

Catégorie

Pharmaceutical products

LOT-0004

Etanercept, Darreichungsform: PLI (ATC-Code: L04AB01)

Hiermit wird die Aufhebung des Verfahrens 2026-03 der ursprünglichen Veröffentlichung ( 822904-2025 vom 11.12.2025) zum 30.06.2026 bekanntgegeben.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DEA51, Germany

Durée

Mar 2026 - Mar 2028

Catégorie

Pharmaceutical products

Détails de la procédure

Date de publication
25 May 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
354716-2026

Documents (1)

Portail de soumission 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3